Latest news

Media Inquiries

Tim Walsh, Walsh Marketing Group
media@informeddna.com

October 17, 2024

Press Release: Phenomix Sciences and InformedDNA Partner to Advance Genetics-Driven Obesity Care

Launching at HLTH 2024, the groundbreaking partnership offers payers, health systems, employers, and life science organizations access to personalized obesity care and treatment planning based on a patient’s DNA...

September 6, 2024

The Cancer Letter: Joint byline, ‘Is gastrectomy indicated?’

A study recently published in JAMA sheds light on cancer risks associated with carrying germline CDH1 mutations, challenging previous, potentially inflated, lifetime cancer risk estimates. InformedDNA, FORCE: Facing Our Risk of Cancer Empowered, and No Stomach For Cancer, collaborate as patient advocates, educators, and experts to support individuals and families impacted by gastric cancer to help them navigate this complex genetic landscape. Subscribers to The Cancer Letter can login to read the full article.

July 25, 2024

Life Sciences Review: InformedDNA Featured Cover Story, Genetic Testing Edition

Actionable Genomic Insights for Successful Clinical Trials: A powerful genomic force is behind the growing success of clinical trials for drug development of rare diseases. InformedDNA CEO, Dr. Surya Singh shares their winning strategy, powered by their remote genetic experts and deep insights, that boosts accurate patient enrollment, improves retention rates, and empowers informed decision-making for life science clients.

June 7, 2024

The Cancer Letter: Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

In a guest byline published in The Cancer Letter, InformedDNA’s chief medical officer and co-founder, Dr. Rebecca Sutphen describes the importance of paired tumor-germline testing in cancer patients and the critical role of genetics specialists in enhancing that care. Subscribers to The Cancer Letter can login to read the full article.

Life Sciences Review

InformedDNA Featured Cover Story, Genetic Testing Edition

How Can We Help?

Reach out today to discover how our dynamic solutions can help your organization make informed decisions, manage utilization of genetic tests, and control spending for cost-effective enhanced patient care and better outcomes for all.